ロード中...
CD105 (Endoglin) as negative prognostic factor in AML
While several genetic and morphological markers are established and serve to guide therapy of acute myeloid leukaemia (AML), there is still profound need to identify additional markers to better stratify patients. CD105 (Endoglin) is a type I transmembrane protein reported to induce activation and p...
保存先:
| 出版年: | Sci Rep |
|---|---|
| 主要な著者: | , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2019
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6892812/ https://ncbi.nlm.nih.gov/pubmed/31797971 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-019-54767-x |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|